WNT5A, Wnt family member 5A, 7474

N. diseases: 375; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.090 AlteredExpression phenotype BEFREE Mechanistically, we uncovered a significant positive correlation between WNT5A expression and YAP1 activity in human PDAC and demonstrated that WNT5A overexpression led to YAP1 activation and recapitulated a YAP1-dependent but Kras-independent phenotype of tumor progression and maintenance. 31557131 2019
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.090 AlteredExpression phenotype BEFREE Negative Wnt5a protein expression might contribute to the tumor progression and poor prognosis of TNBC and might be a new therapy target in TNBC. 26721633 2016
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.090 Biomarker phenotype BEFREE Overexpression of wingless-type MMTV integration site family 5A (WNT5A) plays a significant role in melanoma cancer progression; however, the mechanism(s) involved remains unknown. 26970271 2016
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.090 AlteredExpression phenotype BEFREE Restored expression of Wnt5a weakened miR‑154‑mediated suppression of tumor progression. 26708300 2016
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.090 AlteredExpression phenotype BEFREE Restored expression of Wnt5a weakened miR-217-mediated suppression of tumor progression. 26054690 2015
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.090 Biomarker phenotype BEFREE These data indicate that WNT5A has a broader function on tumor progression and metastatic spread than previously known; by inducing exosome-release of immunomodulatory and pro-angiogenic factors that enhance the immunosuppressive and angiogenic capacity of the tumors thus rendering them more aggressive and more prone to metastasize. 24766647 2014
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.090 Biomarker phenotype BEFREE Wnt5a has been shown to be involved in cancer progression in a variety of tumor types. 24696716 2014
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.090 Biomarker phenotype BEFREE These data identify WNT5A as important target of CUTL1 and as novel mediator of invasiveness and tumor progression in pancreatic cancer. 17227781 2007
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.090 AlteredExpression phenotype BEFREE The present study revealed that an overexpression of Wnt5a could produce more aggressive NSCLC, especially in squamous cell carcinomas, during tumor progression. 16314637 2005